Abstract: The present invention relates to the use of mesenchymal stromal cells (MSCs) for the treatment of supralethal radiation injury.

Abstract: The invention relates to the production of retina-specific cells from human adult bone marrow stem cells by culturing bone marrow stem cells in the presence of a differentiation medium. The invention also relates to retina-specific cells and to the use of these cells for treating diseases associated with acquired or congenital dysfunction of the retinal pigment epithelium, cells of adjacent structures of the entire retina and of the choroid coat as well as of other eye tissue.

Abstract: The present invention concerns the use of CD34 or a polypeptide derived therefrom as cell-surface/gene transfer marker. In particular the object of the invention is a gene transfer vector and host cells transduced by the vector, the vector containing a transgene and a nucleic acid sequence coding for CD34, a fragment of suitable for use in procedures for identification and/or selection of genetically modified cells and in gene therapy. The invention thus further concerns kits for carrying out these procedures and the use of the vector in vitro and as vivo.